NCT04314609

Brief Summary

To re-investigate the success rate of Ultrasound guided sacroiliac joint steroid injection in depositing the drug inside the joint capsule (confirmed by contrast spread in fluoroscopy) and if there is a difference in clinical outcome between injections done strictly inside the joint and injections done periarticular.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
34

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2019

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2019

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

March 17, 2020

Completed
2 days until next milestone

First Posted

Study publicly available on registry

March 19, 2020

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2020

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2020

Completed
Last Updated

June 18, 2020

Status Verified

June 1, 2020

Enrollment Period

7 months

First QC Date

March 17, 2020

Last Update Submit

June 16, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • success rate of ultrasound sacroiliac joint injection

    Percent of successful intraarticular drug injections during USG SIJ steroid injection (as confirmed by contrast spread in fluoroscopy)

    Immediately after injection

Secondary Outcomes (2)

  • Difference in clinical outcome between intraarticular and periarticular injections.

    After 10 minutes, 1 week and 1 month

  • Clinical improvement

    After 10 minutes, 1 week ,1 month

Study Arms (1)

Ultrasound , fluroscope

EXPERIMENTAL

After injection of corticosteroids with 1 ml contrast in sacroiliac joint using ultrasound and withdrawal of the needle, an antero-posterior fluoroscopy image will be obtained and recorded for the injected joint to detect the spread pattern of the contrast and whether its pre-dominantly intra or periarticular.

Device: Ultrasonography, fluoroscopy

Interventions

success rate of Ultrasound guided SIJ steroid injection confirmed by contrast spread in fluoroscopy

Ultrasound , fluroscope

Eligibility Criteria

Age16 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Subject has sacroiliitis (acute or chronic) by history.
  • Failed conservative therapy eg. bed rest, anti-inflammatory medications and physical therapy for at least 6 weeks.

You may not qualify if:

  • Subject has BMI above 35 kg/m2
  • Coagulopathy.
  • Renal or Hepatic Failure.
  • Current Pregnancy or actively pursuing pregnancy.
  • Known allergy to local anesthetic or steroids.
  • Infection at site of needle placement or SIJ infection.
  • Prior surgical procedures involving the SIJ.
  • Previous surgical Fixation involving the lumbar spine.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of medicine cairo university

Cairo, 11562, Egypt

Location

MeSH Terms

Conditions

Sacroiliitis

Interventions

UltrasonographyFluoroscopy

Condition Hierarchy (Ancestors)

ArthritisJoint DiseasesMusculoskeletal Diseases

Intervention Hierarchy (Ancestors)

Diagnostic ImagingDiagnostic Techniques and ProceduresDiagnosisRadiography

Study Officials

  • Amany E Ayad, M.D

    Cairo University

    PRINCIPAL INVESTIGATOR
  • Ahmed Z Fouad, M.D

    Cairo University

    STUDY CHAIR
  • Mohamed A Mansour, M.D

    Cairo University

    STUDY CHAIR
  • Karim A Tawfik, MSc

    Cairo University

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Doctor

Study Record Dates

First Submitted

March 17, 2020

First Posted

March 19, 2020

Study Start

October 1, 2019

Primary Completion

May 1, 2020

Study Completion

June 1, 2020

Last Updated

June 18, 2020

Record last verified: 2020-06

Data Sharing

IPD Sharing
Will not share

Locations